Albaron Partners Acquires SpringCreek Fertility

New York, NY, and Columbus, OH, March 2, 2022 - SpringCreek Fertility, an Ohio-based regional leader in reproductive endocrinology, and Albaron Partners, LP, today announced that SpringCreek Fertility has been acquired by affiliates of Albaron and will become part of Innovation Fertility, Albaron's reproductive endocrinology platform. The financial terms of the transaction were not disclosed. Founder and Chief Medical Officer Dr. Jeremy Groll has retained a minority ownership stake.

Based in Columbus, OH, SpringCreek Fertility is a state-of-the-art fertility center offering comprehensive reproductive health treatment options, including in vitro fertilization, egg donation, genetic testing, intrauterine insemination, egg freezing and gestational carrying. Founded in 2014, its award-winning team completes around 600 IVF cycles each year.

Innovation Fertility provides patients with innovative fertility treatment options, combining premier reproductive endocrinologists with experienced laboratory managers and operators to deliver exceptional care and an unparalleled patient experience.